The DOI matches its Crossref record; 284 of the 284 references it cites were found in a registry or an index.
50 years of hurdles and hope in anxiolytic drug discovery
Open accessAbstract
Anxiety disorders are the most prevalent group of psychiatric diseases, and have high personal and societal costs. The search for novel pharmacological treatments for these conditions is driven by the growing medical need to improve on the effectiveness and the side effect profile of existing drugs. A huge volume of data has been generated by anxiolytic drug discovery studies, which has led to the progression of numerous new molecules into clinical trials. However, the clinical outcome of these efforts has been disappointing, as promising results with novel agents in rodent studies have very rarely translated into effectiveness in humans. Here, we analyse the major trends from preclinical studies over the past 50 years conducted in the search for new drugs beyond those that target the prototypical anxiety-associated GABA (γ-aminobutyric acid)–benzodiazepine system, which have focused most intensively on the serotonin, neuropeptide, glutamate and endocannabinoid systems. We highlight various key issues that may have hampered progress in the field, and offer recommendations for how anxiolytic drug discovery can be more effective in the future.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Items 201–284 of 284
Increased fearfulness of Fyn tyrosine kinase deficient mice
Miyakawa, T., Yagi, T., Watanabe, S., & Niki, H. (1994) · Molecular Brain Research · doi:10.1016/0169-328x(94)90201-1 · Cited by 81
Bhatnagar, S., Nowak, N., Babich, L., & Bok, L. (2004) · Behavioural Brain Research · doi:10.1016/j.bbr.2004.01.018 · Cited by 80
Muigg, P., Scheiber, S., Salchner, P., Bunck, M., Landgraf, R., & Singewald, N. (2009) · PLoS ONE · doi:10.1371/journal.pone.0005346 · Cited by 80
Zhao, L., Kim, K. W., Ikeda, Y., Anderson, K. K., Beck, L., Chase, S., Tobet, S. A., & Parker, K. L. (2008) · Molecular Endocrinology · doi:10.1210/me.2008-0034 · Cited by 80
Armario, A., Hernández, J., Bluethmann, H., & Hidalgo, J. (1998) · Journal of Neuroimmunology · doi:10.1016/s0165-5728(98)00199-4 · Cited by 78
Autonomic Changes Associated with Enhanced Anxiety in 5-HT1A Receptor Knockout Mice
Pattij, T. (2002) · Neuropsychopharmacology · doi:10.1016/s0893-133x(02)00317-2 · Cited by 78
Pharmacokinetic and pharmacodynamic interactions of bretazenil and diazepam with alcohol
van Steveninck, A. L., Gieschke, R., Schoemaker, R. C., Roncari, G., Tuk, B., Pieters, M. S. M., Breimer, D. D., & Cohen, A. F. (1996) · British Journal of Clinical Pharmacology · doi:10.1046/j.1365-2125.1996.38514.x · Cited by 78
Shimazaki, T., Yoshimizu, T., & Chaki, S. (2006) · CNS Drugs · doi:10.2165/00023210-200620100-00002 · Cited by 78
Blanchard, D. C., Griebel, G., & Blanchard, R. J. (1995) · Journal of Psychopharmacology · doi:10.1177/026988119500900201 · Cited by 77
Self-citationAcute and chronic effects of three benzodiazepines in the social interaction anxiety test in mice
Angelis, L. D., & File, S. E. (1979) · Psychopharmacology · doi:10.1007/bf00496051 · Cited by 75
Osada, T., Ikegami, S., Takiguchi‐Hayashi, K., Yamazaki, Y., Fukui, Y., Higashinakagawa, T., Sakaki, Y., & Takeuchi, T. (1999) · Journal of Neuroscience · doi:10.1523/jneurosci.19-14-06068.1999 · Cited by 73
Heiming, R. S., Jansen, F., Lewejohann, L., Kaiser, S., Schmitt, A., Lesch, K. P., & Sachser, N. (2009) · Frontiers in Behavioral Neuroscience · doi:10.3389/neuro.08.026.2009 · Cited by 73
Classical and novel approaches to the preclinical testing of anxiolytics: A critical evaluation
Haller, J., Aliczki, M., & Gyimesi-Pelczer, K. (2012) · Neuroscience & Biobehavioral Reviews · doi:10.1016/j.neubiorev.2012.09.001 · Cited by 72
de Haas, S., Franson, K. L., Schmitt, J. A. J., Cohen, A., Fau, J., Dubruc, C., & van Gerven, J. (2008) · Journal of Psychopharmacology · doi:10.1177/0269881108092595 · Cited by 72
The Maudsley Reactive and Nonreactive Strains: A New Perspective
Blizard, D. A., & Adams, N. (2002) · Behavior Genetics · doi:10.1023/a:1020206120248 · Cited by 71
Chandra, D., Korpi, E. R., Miralles, C. P., Blas, A. L. D., & Homanics, G. E. (2005) · BMC Neuroscience · doi:10.1186/1471-2202-6-30 · Cited by 71
CRH Overproduction in Transgenic Mice: Behavioral and Immune System Modulationa
Stenzel‐Poore, M. P., Duncan, J. E., Rittenberg, M. B., Bakke, A. C., & Heinrichs, S. C. (1996) · Annals of the New York Academy of Sciences · doi:10.1111/j.1749-6632.1996.tb15110.x · Cited by 68
Hasegawa, S., Furuichi, T., Yoshida, T., Endoh, K., Kato, K., Sado, M., Maeda, R., Kitamoto, A., Miyao, T., Suzuki, R., et al. (2009) · Molecular Brain · doi:10.1186/1756-6606-2-6 · Cited by 68
Line, S. J., Barkus, C., Coyle, C., Jennings, K. A., Deacon, R. M. J., Lesch, K., Sharp, T., & Bannerman, D. M. (2010) · European Neuropsychopharmacology · doi:10.1016/j.euroneuro.2010.08.005 · Cited by 68
Li, Q., Holmes, A., Ma, L., de Kar, L. D. V., García, F., & Murphy, D. L. (2004) · Journal of Neuroscience · doi:10.1523/jneurosci.3223-04.2004 · Cited by 66
Self-citationThe serotonin 1A receptor gene as a genetic and prenatal maternal environmental factor in anxiety
Gleason, G., Liu, B., Bruening, S., Zupan, B., Auerbach, A. D., Mark, W. H., Oh, J.-E., Toth, J. G., Lee, F., & Tóth, M. (2010) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0914805107 · Cited by 63
Altered conditioned fear behavior in glutamate decarboxylase 65 null mutant mice
Stork, O., Yamanaka, H., Stork, S., Kume, N., & Obata, K. (2003) · Genes Brain & Behavior · doi:10.1034/j.1601-183x.2003.00008.x · Cited by 63
Steimer, T., Driscoll, P., & Schulz, P. (1997) · Journal of Neuroendocrinology · doi:10.1046/j.1365-2826.1997.t01-1-00571.x · Cited by 61
Bergink, V., & Westenberg, H. G. M. (2005) · International Clinical Psychopharmacology · doi:10.1097/00004850-200511000-00001 · Cited by 61
Ouagazzal, A., Moreau, J., Pauly-Evers, M., & Jenck, F. (2003) · Behavioural Brain Research · doi:10.1016/s0166-4328(03)00066-4 · Cited by 61
High social anxiety and low aggression in Fawn-Hooded rats
Kantor, S., Anheuer, Z. E., & Bagdy, G. (2000) · Physiology & Behavior · doi:10.1016/s0031-9384(00)00374-7 · Cited by 61
Dixon, C. I., Rosahl, T. W., & Stephens, D. N. (2008) · Pharmacology Biochemistry and Behavior · doi:10.1016/j.pbb.2008.01.015 · Cited by 61
Evaluation of the mGlu8 receptor as a putative therapeutic target in schizophrenia
Robbins, M. J., Starr, K. R., Honey, A., Soffin, E. M., Rourke, C., Jones, G. A., Kelly, F. M., Strum, J. C., Melarange, R. A., Harris, A. J., et al. (2007) · Brain Research · doi:10.1016/j.brainres.2007.03.028 · Cited by 60
Chen, Q., Nakajima, A., Meacham, C. E., & Tang, Y. (2006) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0505407103 · Cited by 60
Resolving differences in GABAA receptor mutant mouse studies
Crestani, F., Martin, J. R., Möhler, H., & Rudolph, U. (2000) · Nature Neuroscience · doi:10.1038/80553 · Cited by 59
Altered anxiety-related behavior in nociceptin/orphanin FQ receptor gene knockout mice
Gavioli, E. C., Rizzi, A., Marzola, G., Zucchini, S., Regoli, D. C., & Calò, G. (2007) · Peptides · doi:10.1016/j.peptides.2007.04.012 · Cited by 59
Reliability of high and low anxiety-related behaviour:
Salomé, N., Viltart, O., Darnaudéry, M., Salchner, P., Singewald, N., Landgraf, R., Sequeira, H., & Wigger, A. (2002) · Behavioural Brain Research · doi:10.1016/s0166-4328(02)00135-3 · Cited by 58
Exploratory and Displacement Behavior in Transgenic Mice Expressing High Levels of Brain TNF-α
Fiore, M., Alleva, E., Probert, L., Kollias, G. A., Angelucci, F., & Aloe, L. (1998) · Physiology & Behavior · doi:10.1016/s0031-9384(97)00514-3 · Cited by 58
Effects of serotonergic lesions on investigatory responding by rats in a holeboard
Geyer, M. A., Petersen, L. R., & Rose, G. J. (1980) · Behavioral and Neural Biology · doi:10.1016/s0163-1047(80)91041-9 · Cited by 57
Mombereau, C., Kawahara, Y., Gundersen, B. B., Nishikura, K., & Blendy, J. A. (2010) · Neuropharmacology · doi:10.1016/j.neuropharm.2010.06.009 · Cited by 56
The Influence of a Targeted Deletion of the IFNγ Gene on Emotional Behaviors
Kustova, Y., Sei, Y., Morse, H. C., & Basile, A. S. (1998) · Brain Behavior and Immunity · doi:10.1006/brbi.1998.0546 · Cited by 56
Sonner, J. M., Cascio, M., Xing, Y., Fanselow, M. S., Kralic, J. E., Morrow, A. L., Korpi, E. R., Hardy, S. L., Sloat, B. R., Eger, E. I., et al. (2005) · Molecular Pharmacology · doi:10.1124/mol.104.009936 · Cited by 56
Dierssen, M., Gratacòs, M., Sahún, I., Martín, M., Gallego, X., Amador‐Arjona, A., de Lagrán, M. M., Murtra, P., Martí, E., Pujana, M. Á., et al. (2006) · Neurobiology of Disease · doi:10.1016/j.nbd.2006.07.015 · Cited by 53
Sun, Y., Zupan, B., Raaka, B. M., Tóth, M., & Gershengorn, M. C. (2008) · Neuropsychopharmacology · doi:10.1038/npp.2008.217 · Cited by 53
Altered response to benzodiazepine anxiolytics in mice lacking GABAB(1) receptors
Mombereau, C., Kaupmann, K., van der Putten, H., & Cryan, J. F. (2004) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2004.06.036 · Cited by 53
Measures of anxiety, sensorimotor function, and memory in male and female mGluR4−/− mice
Davis, M. J., Haley, T., Duvoisin, R. M., & Raber, J. (2012) · Behavioural Brain Research · doi:10.1016/j.bbr.2011.12.037 · Cited by 52
Anxiety and cognition in female histidine decarboxylase knockout (Hdc−/−) mice
Acevedo, S. F., Pfankuch, T., Ohtsu, H., & Raber, J. (2005) · Behavioural Brain Research · doi:10.1016/j.bbr.2005.10.016 · Cited by 52
Surget, A., Leman, S., Griebel, G., Belzung, C., & Yalçın, İ. (2006) · CNS & Neurological Disorders - Drug Targets · doi:10.2174/187152706776359682 · Cited by 52
Self-citationEhninger, D., & Silva, A. J. (2010) · Behavior Genetics · doi:10.1007/s10519-010-9398-1 · Cited by 51
Characterization of 5-HT1A/1B−/− mice: An animal model sensitive to anxiolytic treatments
Guilloux, J., David, D. J. P., Xia, L., Nguyen, H. T., Rainer, Q., Guiard, B. P., Repérant, C., Deltheil, T., Tóth, M., Hen, R., et al. (2011) · Neuropharmacology · doi:10.1016/j.neuropharm.2011.02.009 · Cited by 51
The Orphanin FQ/Nociceptin (OFQ/N) System
Civelli, O. (2008) · Springer eBooks · doi:10.1007/400_2007_057 · Cited by 49
Effects of chronic nicotine on food intake and anxiety-like behaviour in CB1 knockout mice
Bura, S. A., Burokas, A., Martín‐García, E., & Maldonado, R. J. (2010) · European Neuropsychopharmacology · doi:10.1016/j.euroneuro.2010.02.003 · Cited by 48
Anxiety-like behavior in transgenic mice with brain expression of neuropeptide Y.
Inui, A., Okita, M., Nakajima, M., Momose, K., Ueno, N., Teranishi, A., Miura, M., Hirosue, Y., Sano, K., Sato, M., et al. (1998) · PubMed · Cited by 48
Touriño, C., Ledent, C. A., Maldonado, R. J., & Valverde, O. (2007) · Biological Psychiatry · doi:10.1016/j.biopsych.2007.09.003 · Cited by 46
Owen, D. R., Lewis, A., Reynolds, R., Rupprecht, R., Eser, D., Wilkins, M. R., Bennacef, I., Nutt, D., & Parker, C. A. (2010) · Synapse · doi:10.1002/syn.20884 · Cited by 45
Kobayashi, S., Ohta, M., Miyasaka, K., & Funakoshi, A. (1996) · Neuroscience Letters · doi:10.1016/0304-3940(96)12881-0 · Cited by 44
Role of apolipoprotein E in anxiety
Raber, J. (2007) · Neural Plasticity · doi:10.1155/2007/91236 · Cited by 44
Pharmacological Treatment of Generalized Anxiety Disorder
Baldwin, D. S., Ajel, K. I., & Garner, M. J. (2009) · Current topics in behavioral neurosciences · doi:10.1007/7854_2009_2 · Cited by 43
Genetic approaches for understanding the role of serotonin receptors in mood and behavior
Donaldson, Z. R., Nautiyal, K. M., Ahmari, S. E., & Hen, R. (2013) · Current Opinion in Neurobiology · doi:10.1016/j.conb.2013.01.011 · Cited by 42
Pharmacotherapy of Social Anxiety Disorder
Ganasen, K. A., & Stein, D. J. (2009) · Current topics in behavioral neurosciences · doi:10.1007/7854_2009_1 · Cited by 41
Opposing roles of mGluR8 in measures of anxiety involving non-social and social challenges
Duvoisin, R. M., Villasana, L., Davis, M. J., Winder, D. G., & Raber, J. (2011) · Behavioural Brain Research · doi:10.1016/j.bbr.2011.02.049 · Cited by 40
Genetic Approaches to Modeling Anxiety in Animals
Jacobson, L. H., & Cryan, J. F. (2009) · Current topics in behavioral neurosciences · doi:10.1007/7854_2009_31 · Cited by 40
Bailey, S., & Tóth, M. (2004) · Journal of Neuroscience · doi:10.1523/jneurosci.0563-04.2004 · Cited by 40
Pharmacologic Treatment of Panic Disorder
Stein, M. B., Steckler, T., Lightfoot, J., Hay, E., & Goddard, A. W. (2010) · Current topics in behavioral neurosciences · doi:10.1007/7854_2009_35 · Cited by 36
NMDAR2B tyrosine phosphorylation regulates anxiety-like behavior and CRF expression in the amygdala
Delawary, M., Tezuka, T., Kiyama, Y., Yokoyama, K., Inoue, T., Hattori, S., Hashimoto, R., Umemori, H., Manabe, T., Yamamoto, T. S., et al. (2010) · Molecular Brain · doi:10.1186/1756-6606-3-37 · Cited by 36
Increased anxiety behavior in OLETF rats without cholecystokinin-A receptor
Yamamoto, Y., Akiyoshi, J., Kiyota, A., et al. (2000) · Brain Research Bulletin · doi:10.1016/s0361-9230(00)00407-x · Cited by 35
Thiébot, M.-H., Dangoumau, L., Richard, G., & Puech, A. J. (1991) · Psychopharmacology · doi:10.1007/bf02244298 · Cited by 35
Benzodiazepine anti-conflict effects in maudsley reactive (MR/Har) and non-reactive (MNRA/Har) rats
Commissaris, R. L., Harrington, G. M., & Altman, H. J. (1990) · Psychopharmacology · doi:10.1007/bf02244595 · Cited by 34
Effects of buspirone and related compounds on suppressed operant responding in rats.
Sanger, D. J. (1990) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1016/s0022-3565(25)12635-9 · Cited by 32
Griebel, G., & Beeské, S. (2011) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2011.09.007 · Cited by 31
Self-citationChung, S., Verheij, M. M. M., Hesseling, P., van Vugt, R. W. M., Buell, M. R., Belluzzi, J. D., Geyer, M. A., Martens, G. J. M., & Civelli, O. (2011) · PLoS ONE · doi:10.1371/journal.pone.0019286 · Cited by 28
Linking variability in brain chemistry and circuit function through multimodal human neuroimaging
Fisher, P. M., & Hariri, A. R. (2012) · Genes Brain & Behavior · doi:10.1111/j.1601-183x.2012.00786.x · Cited by 27
Hashemi, E., Sahbaie, P., Davies, M. F., Clark, J. D., & DeLorey, T. M. (2006) · Brain Research · doi:10.1016/j.brainres.2006.10.050 · Cited by 27
Different housing conditions alter the behavioural phenotype of CCK2 receptor-deficient mice
Abramov, U., Raud, S., Innos, J., Lasner, H., Kurrikoff, K., Türna, T., Puussaar, T., Õkva, K., Matsui, T., & Vasar, E. (2008) · Behavioural Brain Research · doi:10.1016/j.bbr.2008.04.027 · Cited by 24
Nothdurfter, C., Rupprecht, R., & Rammes, G. (2012) · Current Topics in Medicinal Chemistry · doi:10.2174/156802612799078748 · Cited by 22
Steckler, T. (2009) · Current topics in behavioral neurosciences · doi:10.1007/7854_2009_14 · Cited by 21
Elevated anxiety-like and depressive behavior in Desert hedgehog knockout male mice
Umehara, F., Mishima, K., Egashira, N., Ogata, A., Iwasaki, K., & Fujiwara, M. (2006) · Behavioural Brain Research · doi:10.1016/j.bbr.2006.07.022 · Cited by 17
Owen, D. R., Rupprecht, R., & Nutt, D. (2012) · Journal of Psychopharmacology · doi:10.1177/0269881112443746 · Cited by 17
Chapter 5.1 Phenomenology of anxiety disorders
Nutt, D., de Miguel, B. G., & Davies, S. (2008) · Handbook of behavioral neuroscience · doi:10.1016/s1569-7339(07)00017-3 · Cited by 16
Sparta, D. R., Fee, J. R., Knapp, D. J., Breese, G. R., & Thiele, T. E. (2007) · Drug and Alcohol Dependence · doi:10.1016/j.drugalcdep.2007.04.001 · Cited by 16
Liljelund, P., Ferguson, C., Homanics, G. E., & Olsen, R. W. (2005) · Epilepsy Research · doi:10.1016/j.eplepsyres.2005.07.005 · Cited by 14
Abnormalities in aggression and anxiety in transgenic mice overexpressing activin E
Sekiyama, K., Hashimoto, O., Ushiro, Y., Adachi, C., Kikusui, T., Tanemura, K., & Hasegawa, Y. (2009) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2009.05.054 · Cited by 12
Bretazenil modulates sleep EEG and nocturnal hormone secretion in normal men
Guldner, J., Trachsel, L., Kratschmayr, C., Rothe, B., Holsboer, F., & Steiger, A. (1995) · Psychopharmacology · doi:10.1007/bf02246085 · Cited by 12
Subchronically applied phencyclidine fails to disrupt prepulse inhibition in rats
Ehrhardt, J., Sabel, B. A., & Schröeder, U. (1999) · European Neuropsychopharmacology · doi:10.1016/s0924-977x(99)00058-9 · Cited by 11
Baldwin, D. S., & Garner, M. J. (2008) · Handbook of behavioral neuroscience · doi:10.1016/s1569-7339(07)00018-5 · Cited by 10
Chapter 4.5 The endocannabinoid system and anxiety responses
Bortolato, M., & Piomelli, D. (2008) · Handbook of Behavioral Neuroscience · doi:10.1016/s1569-7339(07)00014-8 · Cited by 7
The Mouse Defense Test Battery: A Model Measuring Different Facets of Anxiety-Related Behaviors
Griebel, G., & Beeské, S. (2011) · Neuromethods · doi:10.1007/978-1-61779-313-4_6 · Cited by 7
Self-citationÜberlegungen zur Wirksamkeit von Psychopharmaka
Leucht, S., Heres, S., & Davis, J. M. (2011) · Der Nervenarzt · doi:10.1007/s00115-011-3349-9 · Cited by 3
Turiault, M., Cohen, C., & Griebel, G. (2010) · Springer eBooks · doi:10.1007/978-3-540-68706-1_210 · Cited by 3
Self-citation
Cited by
Using Neuroscience to Help Understand Fear and Anxiety: A Two-System Framework
LeDoux, J. E., & Pine, D. S. (2016) · American Journal of Psychiatry · doi:10.1176/appi.ajp.2016.16030353 · Cited by 1,035
Craske, M. G., Stein, M. B., Eley, T. C., Milad, M. R., Holmes, A., Rapee, R. M., & Wittchen, H.-U. (2017) · Nature Reviews Disease Primers · doi:10.1038/nrdp.2017.24 · Cited by 652
Pharmacotherapy of Anxiety Disorders: Current and Emerging Treatment Options
Garakani, A., Murrough, J. W., Freire, R. C., Thom, R. P., Larkin, K., Buono, F. D., & Iosifescu, D. V. (2020) · Frontiers in Psychiatry · doi:10.3389/fpsyt.2020.595584 · Cited by 440
Meningeal γδ T cells regulate anxiety-like behavior via IL-17a signaling in neurons
Alves de Lima, K., Rustenhoven, J., Da Mesquita, S., Wall, M., Salvador, A. F., Smirnov, I., Martelossi Cebinelli, G., Mamuladze, T., Baker, W., Papadopoulos, Z., et al. (2020) · Nature Immunology · doi:10.1038/s41590-020-0776-4 · Cited by 416
Singewald, N., Schmuckermair, C., Whittle, N., Holmes, A., & Ressler, K. J. (2015) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2014.12.004 · Cited by 390
“Various neuropeptides and their corresponding receptors are localized in brain regionsmediating emotional behavior and stress response and have been considered as potential anxiolytic drug targets (Bowers et al., 2012; Ebner et al., 2009; Griebel & Holmes, 2013).”
BackgroundSelf-citation
Metadata
- Authors
- Griebel, G., & Holmes, A.
- Venue
- Nature Reviews Drug Discovery
- Published
- 2013-08-30
- Volume
- 12
- Issue
- 9
- Pages
- 667-687
- ISSN
- 1474-1776 (ISSN-L)
- 1474-1784
- OpenAlex
- W1974420087
- Cited by
- 414
- References
- 284
- FWCI
- 2.28
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.